Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 12, 2020 at 04:58 pm
Share
Sinphar Pharmaceutical Co.,Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 583.059 million compared to TWD 572.514 million a year ago. Operating loss was TWD 25.171 million compared to TWD 68.363 million a year ago. Net income was TWD 8.541 million compared to net loss of TWD 24.917 million a year ago. Basic earnings per share was TWD 0.05 compared to basic loss per share of TWD 0.15 a year ago. For the half year, sales was TWD 1,208.451 million compared to TWD 1,145.387 million a year ago. Operating loss was TWD 12.355 million compared to TWD 88.146 million a year ago. Net income was TWD 35.312 million compared to net loss of TWD 10.625 million a year ago. Basic earnings per share was TWD 0.21 compared to basic loss per share of TWD 0.06 a year ago.
Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Companyâs principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
SINPHAR PHARMACEUTICAL CO.,LTD. 
